UNSPSC 51373470: Homatropine/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373470 Homatropine/hydrocodone is a Commodity code that covers pharmaceutical products—specifically controlled-substance medications and related parenteral supplies—procured by state and local health and correctional agencies. State and local governments buy these products primarily through health departments, correctional systems, and community health programs to support inpatient and incarcerated populations. The recent solicitations show demand for parenteral nutrition solutions, intravenous products, and opioid-antagonist medications such as naloxone, alongside ancillary services including preparation, delivery, and drug deactivation systems. Issuing bodies include state departments of corrections and county health authorities; these agencies typically require vendors to demonstrate clinical expertise in preparation and delivery, maintain specified insurance coverage including professional and cyber liability, and comply with state business licensure and background-clearance requirements.

Geographic activity is concentrated in Washington and Florida based on recent postings. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a due date of October 7, 2026, seeking parenteral products and services for eight correctional facilities across the state with anticipated award to up to three contractors per region; the contract runs November 26, 2026 through June 30, 2030. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building (response deadline July 26, 2023). The Washington solicitation emphasizes set-asides and subcontractor inclusion plans targeting small, minority-owned, women-owned, and veteran-owned businesses, while the Florida procurement does not specify explicit disadvantaged-enterprise designations but requires E-Verify compliance and drug-free workplace certification.